Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Device export policy

This article was originally published in The Gray Sheet

Executive Summary

A device never marketed in the U.S. and without 510(k) clearance does not require an export approval from FDA if the manufacturer has reason to believe the product would be deemed "substantially equivalent," FDA staffers report. The policy supersedes the position taken in FDA's August 1992 publication "Everything You Always Wanted to Know About Medical Device Requirements...and Weren't Afraid to Ask," which specified that such devices must receive export approval letters. The agency's new interpretation is in line, however, with the policy expressed in its August 1990 "Export of Medical Devices: A Workshop Manual"

Latest Headlines
See All
UsernamePublicRestriction

Register

MT002677

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel